Astrana Health, Inc. (NASDAQ:ASTH) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $65.60.

Several analysts have recently issued reports on the stock. Macquarie raised shares of Astrana Health to a “hold” rating in a research report on Monday, December 16th. Stifel Nicolaus reduced their target price on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 20th. Robert W. Baird raised their price target on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Finally, Truist Financial cut their price objective on Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research report on Monday, January 13th.

Astrana Health Stock Down 26.8 %

Shares of NASDAQ ASTH opened at $25.38 on Friday. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The business’s 50 day moving average is $34.84 and its two-hundred day moving average is $44.50. Astrana Health has a 52-week low of $23.12 and a 52-week high of $63.20. The firm has a market cap of $1.43 billion, a price-to-earnings ratio of 19.52, a PEG ratio of 1.37 and a beta of 1.20.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. Research analysts predict that Astrana Health will post 1.15 EPS for the current year.

Institutional Investors Weigh In On Astrana Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Nisa Investment Advisors LLC acquired a new position in shares of Astrana Health during the third quarter worth $35,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in Astrana Health during the 4th quarter worth about $40,000. Quarry LP boosted its position in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company’s stock worth $57,000 after acquiring an additional 471 shares in the last quarter. KBC Group NV purchased a new position in shares of Astrana Health in the 3rd quarter valued at about $70,000. Finally, Quest Partners LLC acquired a new stake in shares of Astrana Health during the 3rd quarter worth about $133,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.